Mauro Magnani

Overview

Best Publications

• KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

  F Loupakis;A Ruzzo;C Cremolini;B Vincenzi

  687
  Citations

• PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer

  Fotios Loupakis;Luca Pollina;Irene Stasi;Annamaria Ruzzo

  506
  Citations

• Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells.

  Vilberto Stocchi;Luigi Cucchiarini;Mauro Magnani;Laura Chiarantini

  409
  Citations

• Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

  Annamaria Ruzzo;Francesco Graziano;Fotios Loupakis;Eliana Rulli

  379
  Citations

• Cell-based drug delivery.

  F. Pierigè;S. Serafini;L. Rossi;M. Magnani

  351
  Citations

• Development of a real-time PCR assay for rapid detection and quantification of Alexandrium minutum (a Dinoflagellate).

  Luca Galluzzi;Antonella Penna;Elena Bertozzini;Magda Vila

  347
  Citations

• High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice.

  Daniele Santini;Fotios Loupakis;Bruno Vincenzi;Irene Floriani

  302
  Citations

• Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals

  Mirko Paiardini;Barbara Cervasi;Barbara Cervasi;Helmut Albrecht;Alagarraju Muthukumar

  285
  Citations

• Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.

  Giuseppe Perrone;Pier Adelchi Ruffini;Vincenzo Catalano;Cathie Spino

  260
  Citations

• The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB).

  M. Magnani;R. Crinelli;M. Bianchi;A. Antonelli

  243
  Citations

• A new platform for Real-Time PCR detection of Salmonella spp., Listeria monocytogenes and Escherichia coli O157 in milk.

  Enrica Omiccioli;Giulia Amagliani;Giorgio Brandi;Mauro Magnani

  215
  Citations

• Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer

  Francesco Graziano;Nadia Galluccio;Paola Lorenzini;Annamaria Ruzzo

  209
  Citations

• Genomic DNA in human blastocoele fluid.

  S. Palini;L. Galluzzi;S. De Stefani;M. Bianchi

  207
  Citations

• Design and characterization of decoy oligonucleotides containing locked nucleic acids.

  Rita Crinelli;Marzia Bianchi;Lucia Gentilini;Mauro Magnani

  201
  Citations

• Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy

  Annamaria Ruzzo;Francesco Graziano;Kazuyuki Kawakami;Go Watanabe

  186
  Citations

• Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART

  Giulia Marchetti;Andrea Gori;Anna Casabianca;Mauro Magnani

  184
  Citations

• Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process.

  J. Matthias Löhr;J. Matthias Löhr;J. Matthias Löhr;Ralf Faissner;Dirk Koczan;Peter Bewerunge

  182
  Citations

• GSH and analogs in antiviral therapy.

  Alessandra Fraternale;Maria Filomena Paoletti;Anna Casabianca;Lucia Nencioni

  178
  Citations

• Erythrocyte-based drug delivery.

  Luiga Rossi;Sonja Serafini;Francesca Pierigé;Antonella Antonelli

  174
  Citations

• Erythrocyte engineering for drug delivery and targeting

  Mauro Magnani;Luigia Rossi;Marcello D'ascenzo;Ivo Panzani

  170
  Citations